Clinical Trial Update: Continued Access Program for Tumor Treating Fields (TTFields) Used With Chemotherapy (Gemcitabine and Nab-Paclitaxel) in Adults With Locally Advanced Pancreatic Cancer (PANOVA-3CA)

View source ↗

Summary

This update notes a continued access program for Tumor Treating Fields in combination with gemcitabine and nab-paclitaxel for adults with locally advanced pancr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Gemzar (gemcitabine)

Snippet

Sponsor: NovoCure GmbH | Conditions: Locally Advanced Pancreatic Adenocarcinoma | Status: TEMPORARILY_NOT_AVAILABLE